CFGS
CRSP icon

Concourse Financial Group Securities’s CRISPR Therapeutics CRSP Stock Holding History

Concourse Financial Group Securities’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$8.84K – 428
2024
Q4 		$8.84K Hold
200
– – ﹤0.01% 1746
2024
Q3 		$9.4K Sell
200
-69
-26% -$3.5K ﹤0.01% 1707
2024
Q2 		$14.5K Buy
269
+66
+33% +$3.82K ﹤0.01% 1592
2024
Q1 		$13.8K Buy
203
+1
+0.5% +$72 ﹤0.01% 1609
2023
Q4 		$12.6K Hold
202
– – ﹤0.01% 1622
2023
Q3 		$9.17K Buy
202
+2
+1% +$103 ﹤0.01% 1674
2023
Q2 		$11.2K Hold
200
– – ﹤0.01% 1617
2023
Q1 		$9.05K Hold
200
– – ﹤0.01% 1692
2022
Q4 		$8.13K Buy
+200
New +$10.6K ﹤0.01% 1725
2022
Q3 		– Sell
-200
Closed -$14.5K – 2108
2022
Q2 		$12K Hold
200
– – ﹤0.01% 1599
2022
Q1 		$13K Sell
200
-225
-53% -$14.1K ﹤0.01% 1607
2021
Q4 		$32K Sell
425
-76
-15% -$6.64K ﹤0.01% 1465
2021
Q3 		$56K Sell
501
-39
-7% -$4.9K ﹤0.01% 1259
2021
Q2 		$87K Buy
540
+62
+13% +$7.54K 0.01% 1048
2021
Q1 		$58K Buy
478
+232
+94% +$35K ﹤0.01% 1167
2020
Q4 		$38K Buy
246
+63
+34% +$7.45K ﹤0.01% 1234
2020
Q3 		$15K Sell
183
-57
-24% -$5.06K ﹤0.01% 1441
2020
Q2 		$18K Buy
240
+140
+140% +$8.19K ﹤0.01% 1323
2020
Q1 		$4K Hold
100
– – ﹤0.01% 1701
2019
Q4 		$6K Buy
+100
New +$5.46K ﹤0.01% 1567

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Concourse Financial Group Securities's CRSP Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of CRISPR Therapeutics (CRSP) in Q1 2025, closing a stake of 200 shares — an estimated $8.84K sold.

Concourse Financial Group Securities first reported a position in CRSP in Q4 2019 and held it in 20 quarters. The position peaked at $87K in Q2 2021. 396 funds tracked by Wall St. Rank hold CRSP as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining CRISPR Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 200 CRISPR Therapeutics shares in Q1 2025, an estimated $8.84K.
  • Concourse Financial Group Securities first reported a position in CRISPR Therapeutics in Q4 2019 and held it in 20 quarters.
  • Concourse Financial Group Securities's CRISPR Therapeutics position peaked at $87K in Q2 2021.
  • 396 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.